Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population

Human Immunology

Volumn 74, Issue 3, 2013, Pages 348-352

  Bharti, Vijaya ^a   Mohanti, Bidhu Kalyan ^b   Das, Satya Narayan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; RESTRICTION ENDONUCLEASE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ETHNICITY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CTLA-4 ANTIGEN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TOBACCO; YOUNG ADULT;

EID: 84873715546     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.008     Document Type: Article

References (38)

1. Biennial Report, National Cancer Registry Program. 1988-89, New Delhi, July 1992.
2. Khanna N.N., Srivastava P.K., Khanna S., Das S.N. Intensive chemotherapy for cancer of the oral cavity. Cancer 1983, 52:790-793.
3. Agarwal A., Rani M., Saha G.K., Valarmathi T.M., Bahadur S., Mohanti B.K., et al. Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest 2003, 32:7-30.
4. Manchanda P., Sharma S.C., Das S.N. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma. Oral Dis 2006, 12:455-462.
5. +) cells in human oral squamous cell carcinoma. Cell Oncol 2012, 35:335-343.
6. Das S.N., Khanna N.N., Khanna S. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis. Cancer Invest 1986, 4:207-216.
7. Curiel T.J., Coukos G., Zou L., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004, 10:942-949.
8. Chang M.C., Chiang C.P., Lin C.L., Lee J.J., Hahn L.J., Jeng J.H. Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol 2005, 41:757-775.
9. Gasparoto T., Malaspina T.S., Benevides L., et al. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumour microenvironment. Cancer Immunol Immunother 2010, 59:819-828.
10. Appleman L.J., Berezovskaya A., Grass I., Boussiotis V.A. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol 2000, 164:144-151.
11. Waterhouse P., Penninger J.M., Timms E., et al. Lymphoproliferative disorders with early lethality in mice deficient in ctla-4. Science 1995, 270:985-988.
12. Sabel M.S., Hess S.D., Egilmez M.K., Chen F.A., Bankert R.B. CTLA-4 blockade augment human T lymphocyte-mediated suppression of lung tumor xenograft in SCID mice. Cancer Immunol Immunother 2005, 54:944-952.
13. Ling V., Wu P.W., Finnerty H.F., Sharpe A.H., Gray G.S., Collins M. Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders. Genomics 1999, 60:341-355.
14. Ueda H., Howson J.M., Esposito L., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
15. Sun T., Zhou Y., Yang M., et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 2008, 68:7025-7034.
16. Zheng J., Yu X., Jiang L., Xiao M., Bai B., Lu J., et al. Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis. BMC Cancer 2010, 10:522.
17. Baniasadi V., Narain N., Goswami R., Das S.N. Promoter region -318 C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 2006, 67:383-389.
18. Kämmerer P.W., Toyoshima T., Schöder F., Kämmerer P., Kuhr K., Brieger J., et al. Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma. Oral Oncol 2010, 46:543-548.
19. Wong Y.K., Chang K.W., Cheng C.Y., Liu C.J. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med 2006, 35:51-54.
20. UICC, TNM Classification of Malignant Tumors 2002, Wiley-Liss, New York. 6th ed. L.H. Sobin, C.H. Wittekind (Eds.).
21. Dunn G.P., Old L.J., Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21:137-148.
22. + regulatory cells that control intestinal inflammation. J Exp Med 2000, 192:295-302.
23. Anjos S.M., Tessier M.C., Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab 2004, 89:6257-6265.
24. Li D., Zhang Q., Xu F., Fu Z., Yuan W., Li D., et al. Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of Northeast China. Mol Cell Biochem 2012, 364:283-290.
25. Erfani N., Razmkhah M., Talei A.R., Pezeshki A.M., Doroudchi M., Monabati A., et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogen 2006, 165:114-120.
26. Wang L., Li D., Fu Z., Li H., Jiang W., Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer 2007, 7:173.
27. Su T.H., Chang T.Y., Lee Y.J., et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 2007, 28:1237-1240.
28. Hughes T.A. Regulation of gene expression by alternative untranslated regions. Trends Genet 2006, 22:119-122.
29. Anjos S.M., Shao W., Marchand L., Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism. Genes Immun 2005, 6:305-311.
30. Mayans S., Lackovic K., Nyholm C., Lindgren P., Ruikka K., Eliasson M., et al. Holmberg D (2007) CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med Genet 2007, 8:3.
31. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon reduces the inhibitory function of CTLA-4 and contribute to the pathogenesis of Graves' disease. J Immunol 2000, 165:6606-6611.
32. Jonson C.O., Hedman M., Karlsson Faresjo M., Casas R., Ilonen J., Ludvigsson J., et al. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children. Clin Exp Immunol 2006, 145:48-55.
33. Mapara M.Y., Sykes M. Tolerence and cancer: mechanism of tumor evasion and strategies for breaking tolerance. J Clin Oncol 2004, 22:1136-1151.
34. Maurer M., Loserth S., Kolb-Maurer A., et al. A polymorphism in the human cytotoxic T- lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002, 54:1-8.
35. Anjos S., Nguyen A., Ounissi-Benkalha H., Tessier M.C., Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T lymphocyte antigen 4 results in inefficient glycosylation of susceptibility allele. J Biol Chem 2002, 277:46478-46486.
36. Ghaderi A., Yeganeh F., Kalantari T., Talei A.R., Pezeshki A.M., Doroudchi M., et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 2004, 86:1-7.
37. Hu L., Liu J., Chen X., et al. CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Human Immunol 2010, 71:888-891.
38. Rahimifar S., Erfani N., Sarraf Z., Ghaderi A. CTLA-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol 2010, 19:136-139.